X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-08 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $8.05 | -110,890 | 938,787 | -11% | -$892,894 | |||||
2023-03-07 | RXRX | Borgeson Blake | Dir | S - Sale | $8.33 | -8,885 | 7,585,172 | 0% | -$73,989 | ||||||
| D | 2023-03-02 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $7.92 | -21,000 | 940,927 | -2% | -$166,268 | |||||
2023-03-02 | RXRX | Mubadala Investment Co Pjsc | 10% | P - Purchase | $7.82 | +66,822 | 20,048,796 | 0% | +$522,354 | ||||||
2023-03-01 | RXRX | Mubadala Investment Co Pjsc | 10% | P - Purchase | $7.94 | +48,867 | 19,981,974 | 0% | +$388,082 | ||||||
2023-02-28 | RXRX | Mubadala Investment Co Pjsc | 10% | P - Purchase | $7.97 | +815 | 19,933,107 | 0% | +$6,496 | ||||||
2023-02-27 | RXRX | Mubadala Investment Co Pjsc | 10% | P - Purchase | $7.69 | +52,500 | 19,932,292 | 0% | +$403,725 | ||||||
| D | 2023-02-23 | RXRX | Larson Tina Marriott | Pres, COO | S - Sale+OE | $7.82 | -8,000 | 427,844 | -2% | -$62,540 | |||||
2023-02-24 | RXRX | Mubadala Investment Co Pjsc | 10% | P - Purchase | $7.64 | +109,118 | 19,879,792 | +1% | +$833,552 | ||||||
2023-02-23 | RXRX | Mubadala Investment Co Pjsc | 10% | P - Purchase | $7.79 | +51,864 | 19,770,674 | 0% | +$403,792 | ||||||
2023-02-21 | RXRX | Borgeson Blake | Dir | S - Sale | $7.73 | -8,885 | 7,594,057 | 0% | -$68,708 | ||||||
2023-02-22 | RXRX | Mubadala Investment Co Pjsc | 10% | P - Purchase | $7.83 | +50,941 | 19,718,810 | 0% | +$399,016 | ||||||
2023-02-21 | RXRX | Mubadala Investment Co Pjsc | 10% | P - Purchase | $7.74 | +94,418 | 19,667,869 | 0% | +$731,126 | ||||||
2023-02-17 | RXRX | Mubadala Investment Co Pjsc | 10% | P - Purchase | $7.71 | +63,382 | 19,573,451 | 0% | +$488,986 | ||||||
2023-02-16 | RXRX | Mubadala Investment Co Pjsc | 10% | P - Purchase | $7.90 | +42,682 | 19,510,069 | 0% | +$337,043 | ||||||
| DM | 2023-02-15 | RXRX | Virani Shafique | Chief Business Officer | S - Sale+OE | $8.35 | -9,254 | 187,332 | -5% | -$77,245 | |||||
2023-02-14 | RXRX | Mubadala Investment Co Pjsc | 10% | P - Purchase | $7.95 | +6,300 | 19,467,387 | 0% | +$50,060 | ||||||
2023-02-13 | RXRX | Mubadala Investment Co Pjsc | 10% | P - Purchase | $7.97 | +32,474 | 19,461,087 | 0% | +$258,837 | ||||||
2023-02-10 | RXRX | Mubadala Investment Co Pjsc | 10% | P - Purchase | $7.98 | +11,000 | 19,428,613 | 0% | +$87,808 | ||||||
2023-02-07 | RXRX | Borgeson Blake | Dir | S - Sale | $8.81 | -8,885 | 7,602,942 | 0% | -$78,263 | ||||||
| D | 2023-02-02 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $9.22 | -21,000 | 942,273 | -2% | -$193,561 | |||||
2023-02-01 | RXRX | Mubadala Investment Co Pjsc | 10% | P - Purchase | $7.97 | +600 | 19,417,613 | 0% | +$4,782 | ||||||
| D | 2023-01-26 | RXRX | Larson Tina Marriott | Pres, COO | S - Sale+OE | $8.07 | -8,000 | 203,654 | -4% | -$64,547 | |||||
2023-01-26 | RXRX | Mubadala Investment Co Pjsc | 10% | P - Purchase | $7.99 | +7,886 | 19,417,013 | 0% | +$63,006 | ||||||
2023-01-24 | RXRX | Borgeson Blake | Dir | S - Sale | $8.71 | -8,885 | 7,611,827 | 0% | -$77,368 | ||||||
2023-01-25 | RXRX | Mubadala Investment Co Pjsc | 10% | P - Purchase | $7.88 | +24,526 | 19,409,127 | 0% | +$193,267 | ||||||
| D | 2023-01-17 | RXRX | Virani Shafique | Chief Business Officer | S - Sale+OE | $9.16 | -10,000 | 73,160 | -12% | -$91,561 | |||||
| M | 2022-12-23 | RXRX | Mubadala Investment Co Pjsc | 10% | P - Purchase | $7.50 | +1,029,795 | 19,384,601 | +6% | +$7,725,857 | |||||
2023-01-10 | RXRX | Borgeson Blake | Dir | S - Sale | $7.69 | -8,885 | 7,620,712 | 0% | -$68,283 | ||||||
| D | 2023-01-05 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $7.39 | -21,000 | 525,805 | -4% | -$155,131 | |||||
| D | 2022-12-29 | RXRX | Larson Tina Marriott | Pres, COO | S - Sale+OE | $7.70 | -8,000 | 203,654 | -4% | -$61,566 | |||||
2022-12-27 | RXRX | Borgeson Blake | Dir | S - Sale | $7.25 | -8,885 | 7,628,272 | 0% | -$64,373 | ||||||
| D | 2022-12-15 | RXRX | Virani Shafique | Chief Business Officer | S - Sale+OE | $8.85 | -10,000 | 78,160 | -11% | -$88,525 | |||||
2022-12-13 | RXRX | Borgeson Blake | Dir | S - Sale | $8.96 | -8,885 | 7,637,157 | 0% | -$79,598 | ||||||
| D | 2022-12-01 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $9.04 | -39,710 | 582,805 | -6% | -$358,947 | |||||
2022-11-29 | RXRX | Borgeson Blake | Dir | S - Sale | $8.75 | -8,885 | 7,646,042 | 0% | -$77,786 | ||||||
2022-11-16 | RXRX | Borgeson Blake | Dir | S - Sale | $11.12 | -17,770 | 7,654,927 | 0% | -$197,610 | ||||||
| D | 2022-11-15 | RXRX | Virani Shafique | Chief Business Officer | S - Sale+OE | $12.31 | -10,000 | 83,160 | -11% | -$123,123 | |||||
| D | 2022-11-17 | RXRX | Larson Tina Marriott | Pres, COO | S - Sale+OE | $10.96 | -16,000 | 203,654 | -7% | -$175,402 | |||||
| D | 2022-11-03 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $10.01 | -39,193 | 576,016 | -6% | -$392,200 | |||||
| D | 2022-10-27 | RXRX | Larson Tina Marriott | Pres, COO | S - Sale+OE | $10.72 | -16,000 | 205,107 | -7% | -$171,450 | |||||
| D | 2022-10-14 | RXRX | Virani Shafique | Chief Business Officer | S - Sale+OE | $10.92 | -10,000 | 88,773 | -10% | -$109,180 | |||||
| D | 2022-10-06 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $11.58 | -38,553 | 562,959 | -6% | -$446,574 | |||||
| D | 2022-09-29 | RXRX | Larson Tina Marriott | Pres, COO | S - Sale+OE | $10.86 | -16,000 | 205,107 | -7% | -$173,749 | |||||
| D | 2022-09-15 | RXRX | Virani Shafique | Chief Business Officer | S - Sale+OE | $13.36 | -10,000 | 93,773 | -10% | -$133,635 | |||||
| D | 2022-09-01 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $10.35 | -39,066 | 549,262 | -7% | -$404,199 | |||||
| D | 2022-08-16 | RXRX | Virani Shafique | Chief Business Officer | S - Sale+OE | $12.61 | -30,000 | 98,773 | -23% | -$378,444 | |||||
| D | 2022-08-16 | RXRX | Larson Tina Marriott | Pres, COO | S - Sale+OE | $12.60 | -16,000 | 295,107 | -5% | -$201,637 | |||||
| D | 2022-08-04 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $9.49 | -39,325 | 541,829 | -7% | -$373,058 | |||||
| D | 2022-07-07 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $9.05 | -39,614 | 528,904 | -7% | -$358,647 | |||||
| D | 2022-06-02 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $6.11 | -42,190 | 516,268 | -8% | -$257,625 | |||||
| DM | 2022-05-04 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $6.47 | -55,330 | 511,972 | -10% | -$357,900 | |||||
| DM | 2022-04-28 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $6.14 | -80,675 | 494,052 | -14% | -$495,381 | |||||
| DM | 2022-04-21 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $6.17 | -80,108 | 444,703 | -15% | -$494,275 | |||||
| D | 2022-04-18 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $6.83 | -38,336 | 394,791 | -9% | -$261,842 | |||||
| D | 2022-04-14 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $7.55 | -37,017 | 368,117 | -9% | -$279,630 | |||||
| D | 2022-04-08 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $6.60 | -39,420 | 340,124 | -10% | -$259,991 | |||||
| D | 2022-04-07 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $6.54 | -39,218 | 314,534 | -11% | -$256,520 | |||||
| D | 2022-04-06 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $6.76 | -38,326 | 288,742 | -12% | -$259,119 | |||||
| D | 2022-04-05 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $7.43 | -36,972 | 262,058 | -12% | -$274,518 | |||||
| DM | 2022-03-11 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $6.48 | -336,150 | 234,020 | -59% | -$2,176,801 | |||||
| D | 2022-03-07 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $7.30 | -300,000 | 234,020 | -56% | -$2,188,950 | |||||
| D | 2022-02-22 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $10.22 | -100,000 | 234,020 | -30% | -$1,021,540 | |||||
| D | 2022-01-31 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $11.73 | -19,858 | 23,470 | -46% | -$232,964 | |||||
| DM | 2022-01-13 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $13.76 | -341,000 | 23,470 | -94% | -$4,692,177 | |||||
2022-01-04 | RXRX | Borgeson Blake | Dir | S - Sale | $18.03 | -9,625 | 7,651,146 | 0% | -$173,528 | ||||||
2021-12-21 | RXRX | Borgeson Blake | Dir | S - Sale | $18.75 | -9,625 | 7,660,216 | 0% | -$180,478 | ||||||
2021-12-16 | RXRX | Larson Tina Marriott | Pres, COO | S - Sale | $18.74 | -2,500 | 47,500 | -5% | -$46,848 | ||||||
| D | 2021-12-16 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $20.01 | -200 | 23,470 | -1% | -$4,001 | |||||
| D | 2021-12-13 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $20.02 | -100 | 23,470 | 0% | -$2,002 | |||||
| DM | 2021-12-08 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $20.13 | -11,750 | 23,470 | -33% | -$236,562 | |||||
2021-12-07 | RXRX | Gibson Christopher | CEO | S - Sale | $20.48 | -19,792 | 9,448,091 | 0% | -$405,433 | ||||||
2021-12-07 | RXRX | Borgeson Blake | Dir | S - Sale | $20.32 | -9,625 | 7,669,841 | 0% | -$195,533 | ||||||
2021-12-07 | RXRX | Li Dean Y | Dir | S - Sale | $20.48 | -15,900 | 3,784,311 | 0% | -$325,630 | ||||||
| AM | 2021-11-17 | RXRX | Li Dean Y | Dir | S - Sale | $20.16 | -19,100 | 1,928,163 | -1% | -$384,962 | |||||
2021-11-18 | RXRX | Larson Tina Marriott | Pres, COO | S - Sale | $18.92 | -2,500 | 50,000 | -5% | -$47,308 | ||||||
2021-11-18 | RXRX | Borgeson Blake | Dir | S - Sale | $18.91 | -9,625 | 7,679,466 | 0% | -$182,005 | ||||||
| M | 2021-11-17 | RXRX | Li Dean Y | Dir | S - Sale | $20.16 | -19,100 | 3,800,211 | -1% | -$384,962 | |||||
| D | 2021-04-16 | RXRX | Lux Ventures Iv, L.P. | 10% | P - Purchase | $18.00 | +100,000 | 17,287,095 | +1% | +$1,800,000 | |||||
| D | 2021-04-16 | RXRX | Mubadala Investment Co Pjsc | 10% | P - Purchase | $18.00 | +2,777,777 | 8,740,917 | +47% | +$49,999,986 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |